{
    "nctId": "NCT04927910",
    "briefTitle": "Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance in Breast Cancer",
    "officialTitle": "Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance Symptom Cluster in Breast Cancer Survivors Receiving Aromatase Inhibitors",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Neoplasms, Cancer Survivor",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 21,
    "primaryOutcomeMeasure": "Feasibility measure",
    "eligibilityCriteria": "Inclusion Criteria\n\n* Female adult aged 18 and older;\n* Clinical diagnosis of early-stage (Stage I, II, or IIIa), hormone-receptor-positive breast cancer;\n* Completion of surgery, and/or chemotherapy and/or radiotherapy;\n* Currently taking the third generation of AIs (anastrozole, letrozole, or exemestane) for at least 1 month;\n* Based on their self-reports of moderate symptoms of joint pain and fatigue or sleep disturbance;\n* Willing to comply with the intervention protocol, and\n* Being able to communicate in Chinese .\n\nExclusion Criteria:\n\n* Previous receipt of acupuncture and acupressure within the past six months;\n* Currently receiving medications (unchanged for 3 month), physical therapy and other complementary and alternative medicines for the treatment of joint pain, fatigue and sleep disturbance;\n* Prior joint surgery or fracture during the past six months;\n* Mentally incapable of participating in the study (Hong Kong version of Montreal Cognitive Assessment score\\<22);and\n* Inability to perform self-care (Karnofsky Performance Scale score\\<70).",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}